Sulfamethoxazole + Trimethoprim Tablet Franchise in Ahmedabad

High Strength Antibiotic Tablet Supplier in Mumbai

Cotrimoxazole DS Tablet Distributor in Delhi

Bacterial Infection Treatment PCD Pharma in Bangalore

Sulfamethoxazole Trimethoprim Tablet Stockist in Hyderabad
Antibiotic Tablet Manufacturer & Exporter in Chandigarh

Home/Products /sulfamethoxazole-900mg-trimethoprim-60mg-tablet

Sulfaxol T Plus Tablet

Composition : Sulfamethoxazole (800mg) + Trimethoprim (160mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Sulfaxol T Plus Tablet contains Sulfamethoxazole 800mg + Trimethoprim 160mg, a double-strength antibiotic combination widely prescribed for the management of moderate to severe bacterial infections affecting the respiratory tract, urinary tract, gastrointestinal system, and skin.

This combination works through a dual mechanism of action, where both components inhibit sequential steps in bacterial folic acid synthesis. This results in enhanced antibacterial potency, broader coverage, and effective control of resistant bacterial strains.

The high-strength formulation makes this tablet suitable for serious infections requiring stronger antibacterial intervention, especially in hospital and clinical practice. Its consistent therapeutic performance supports high prescriber confidence and repeat demand.

For PCD pharma franchise partners, Sulfaxol T Plus Tablet is a high-value antibiotic product, offered at the best price for PCD pharma franchise. Strong market demand, broad therapeutic usage, and stable prescription trends make it a profitable and reliable addition to any antibacterial product range.

Read More

About the Product

Sulfaxol T Plus Tablet contains Sulfamethoxazole 800mg + Trimethoprim 160mg, a double-strength antibiotic combination widely prescribed for the management of moderate to severe bacterial infections affecting the respiratory tract, urinary tract, gastrointestinal system, and skin.

This combination works through a dual mechanism of action, where both components inhibit sequential steps in bacterial folic acid synthesis. This results in enhanced antibacterial potency, broader coverage, and effective control of resistant bacterial strains.

The high-strength formulation makes this tablet suitable for serious infections requiring stronger antibacterial intervention, especially in hospital and clinical practice. Its consistent therapeutic performance supports high prescriber confidence and repeat demand.

For PCD pharma franchise partners, Sulfaxol T Plus Tablet is a high-value antibiotic product, offered at the best price for PCD pharma franchise. Strong market demand, broad therapeutic usage, and stable prescription trends make it a profitable and reliable addition to any antibacterial product range.

Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, headache, or mild skin rash. Rare but serious adverse effects include hypersensitivity reactions, hematological abnormalities, liver dysfunction, and severe skin reactions such as Stevens-Johnson syndrome.

Sulfaxol T Plus Tablet is indicated for the treatment of urinary tract infections, respiratory tract infections, gastrointestinal infections, skin and soft tissue infections, and other infections caused by susceptible bacteria, as recommended by a healthcare professional.

This medicine should be taken strictly as prescribed by a healthcare professional. Adequate fluid intake is recommended during therapy to minimize renal complications. Caution is advised in patients with sulfonamide allergy, liver or kidney impairment, and in elderly or immunocompromised patients.

Store Sulfaxol T Tablet at room temperature in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation